Pommerit Jaudy, France

Benôit Ledoussal

This inventor holds 1 USPTO granted patent. Top assignee: Mutabilis. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Benôit Ledoussal: Innovator in Antibacterial Compounds

Introduction

Benôit Ledoussal is a notable inventor based in Pommerit Jaudy, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at combating bacterial infections. His work is characterized by a focus on innovative solutions that address pressing health challenges.

Latest Patents

Ledoussal holds a patent for "Heterocyclic compounds and their use in preventing or treating bacterial infections." This invention relates to heterocyclic compounds, their preparation processes, and pharmaceutical compositions that include these compounds. The patent outlines their use, either alone or in combination with other antibacterial agents and beta-lactam compounds, for the prevention or treatment of bacterial infections. Additionally, it discusses the potential of these compounds as β-lactamase inhibitors and antibacterial agents.

Career Highlights

Benôit Ledoussal is associated with Mutabilis, a company that focuses on innovative pharmaceutical solutions. His work at Mutabilis has allowed him to explore and develop new compounds that have the potential to significantly impact the treatment of bacterial infections. His dedication to research and development is evident in his patent and ongoing projects.

Collaborations

Ledoussal collaborates with talented colleagues, including Julie Brias and Sophie Vomscheid. Their combined expertise contributes to the innovative environment at Mutabilis, fostering advancements in pharmaceutical research.

Conclusion

Benôit Ledoussal's contributions to the field of antibacterial compounds highlight his role as an important inventor in the pharmaceutical industry. His patent reflects a commitment to addressing bacterial infections through innovative solutions. His work continues to inspire advancements in medical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…